Elanco Animal Health Incorporated
- Jurisdiction
United States - LEI
549300SHPNDCE059M934 - ISIN
US28414H1032 (ELAN )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€19.39 12.7% undervalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Read full profile
Fundamentals
- Net revenue
€3.82B - Gross margin
45.8% - EBIT
€178.27M - EBIT margin
4.7% - Net income
€370.18M - Net margin
9.7%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Val Hoyle | October 10, 2025 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |